Liver Disease

People with liver disease or who are immunocompromised should avoid eating raw oysters, according to Dr. William Schaffner. The question of whether flesh-eating bacteria can be obtained from seafood or oysters was raised.

GSK CEO Luke Miels announced a three-year cost-cutting plan targeting 1.9 billion pounds in annual savings by 2029, with funds reinvested into late-stage drug trials. The company aims to increase Phase 3 trials from 10 to 20 this year, focusing on areas like oncology, liver disease, vaccines, and HIV.

The UK drugs watchdog has announced that thousands of people with liver disease will be prescribed the weight-loss medication Wegovy. The decision aims to address the condition through a treatment that reduces weight, which is linked to liver health.

A study from the U.K. Biobank found that coffee consumption is associated with lower risks of serious liver disease and related mortality, with higher intake showing greater benefits over a 13-year follow-up.

Drinking coffee can reduce the risk of deadly liver disease, with scientists identifying the optimal number of daily cups for protection, including benefits for decaf drinkers.

A technology developed by Professor Sangeeta Bhatia and colleagues uses hepatocytes injected with hydrogel microspheres to form liver-like structures, offering an alternative to liver transplants. The cells remain viable in mice for two months and could serve as a bridge to transplantation while researchers explore immune system evasion methods.

A study found that the muscle protein NOX4 declines with age and inactivity in mice, leading to frailty, muscle loss, and health issues. Exercise in older mice restored NOX4 levels, suggesting physical activity helps maintain muscle health and resilience. Josephine Hunt, founder of The Resilience Revolution, emphasized exercise's role in activating biological pathways for healthy aging.

A study challenges the notion that daily alcohol consumption is harmless, suggesting that the safest amount is none. Researchers found that even low levels of alcohol use increase health risks, such as liver disease, stroke, and cancer, and recommend limiting intake to one drink per day if people choose to drink. The study, analyzing alcohol-related injuries and health data, contradicts older guidelines that allowed up to two daily drinks for men.

A patient recounts how prior authorization delays from an insurance company nearly caused their death due to untreated liver disease, highlighting systemic issues in healthcare rationing and bureaucratic hurdles. The author criticizes insurance companies for prioritizing profits over patient care and calls for reform in a system that forces physicians and patients to fight for necessary treatments.

NHS data may enable early detection of liver disease up to years before symptoms appear, particularly among non-drinkers. This breakthrough could help address a rising surge in cases among individuals not associated with alcohol-related risks.

Ordinary people are reversing biological age and healing liver damage through dietary changes. The liver is considered a 'silent organ' and certain signs may indicate trouble. People are using food to improve their health and reverse liver damage.

A major study warns that millions are at risk of deadly liver disease, but experts suggest lifestyle changes could nearly halve cases. The findings highlight the potential for preventive measures to significantly reduce the burden of the disease.

Experts urge European governments to raise taxes on alcohol and unhealthy food to address 284,000 annual liver disease deaths, emphasizing the need to cover costs imposed on health services, criminal justice, and social systems.

Death rates from liver disease have quadrupled, with non-heavy drinkers now at risk. Moderate alcohol consumption, such as a bottle of wine or a gin, significantly increases the risk. The article provides methods to mitigate this damage.

Death rates from liver disease have quadrupled, with moderate alcohol consumption like a bottle of wine or a gin now posing significant risks. The article highlights that non-heavy drinkers are also affected and suggests ways to mitigate the damage.

A 47-year-old individual developed liver disease after nightly alcohol consumption, quit alcohol for a year, lost three stone, and reversed their condition through lifestyle changes.

A study warns of a rising risk of liver disease as 1 in 10 adults are both obese and heavy drinkers, creating dangerous conditions for a 'silent killer.' The combination of obesity and excessive alcohol consumption is highlighted as a critical public health concern.

A study warns of a potential liver disease epidemic as one in 10 adults are both obese and heavy drinkers, creating ideal conditions for a 'silent killer' health crisis. The combination of obesity and excessive alcohol consumption is highlighted as a critical risk factor for liver disease.

A study warns of a rising liver disease crisis as one in ten adults are both obese and heavy drinkers, creating a high-risk combination for the 'silent killer' condition. The dual factors of obesity and excessive alcohol consumption are identified as key contributors to the surge in liver disease cases.

A 47-year-old individual reversed their liver disease by quitting alcohol for a year and losing three stone (42 pounds), highlighting the impact of lifestyle changes on health conditions.

A 47-year-old individual diagnosed with liver disease quit alcohol, lost three stone, and started exercising, but tests showed ongoing issues. After identifying a key factor, they reversed their condition.

Scientists discovered that the hormone FGF21 reverses obesity in mice by activating a brain circuit in the hindbrain linked to metabolism. Unlike GLP-1 drugs like Ozempic and Wegovy, FGF21 boosts energy burning instead of suppressing appetite, offering potential for new weight-loss and liver disease treatments.

A liver disease epidemic is expanding to non-drinkers, with projections indicating 1.8 billion people will be affected by 2050. Most individuals remain unaware of their condition despite its growing prevalence.

A liver disease epidemic is spreading to non-drinkers globally, with projections indicating 1.8 billion people will be affected by 2050. The article highlights growing awareness gaps about the condition's prevalence and risks.

Liver disease is becoming an epidemic, affecting non-drinkers in record numbers. Projections indicate 1.8 billion people will be impacted by 2050, with most unaware of their condition.

A liver disease epidemic is expanding to non-drinkers, with projections indicating 1.8 billion people will be affected by 2050. The article highlights growing awareness gaps about this deadly condition.

The article highlights several health risks linked to lifestyle factors such as alcohol consumption, sleep patterns, and diet. It also mentions potential interventions like vaccines and drugs for conditions like Alzheimer's and liver disease.